A study by Massachusetts General Hospital (MGH) investigators finds, for the first time, that women with a history of acute kidney injury with complete clinical recovery have an increase of several adverse outcomes of pregnancy – including premature delivery and preeclampsia, a condition that is hazardous for both mother and baby – even though they appear to have normal kidney function prior to pregnancy. Their findings are being published online in the Journal of the American Society of Nephrology.
“Our findings that women with a history of acute kidney injury were at increased risk of complications including preeclampsia are important, because all of these women appeared to have recovered from their kidney injury prior to pregnancy,” says Jessica Sheehan Tangren, MD, of the MGH Division of Nephrology, lead and corresponding author of the report. “They would not necessarily have been identified as at high risk for pregnancy complications.”
While acute kidney injury is primarily seen in the elderly and in critically ill individuals, it can occur in children or young adults hospitalized for conditions including serious infections, major surgery, trauma or from medication side effects or interactions. Existing kidney disease is recognized to increase the risk for pregnancy complications, but the possibility that a previous episode of acute kidney injury could also increase risk had not previously been investigated.
To address that question the research team analyzed medical records for all women who delivered babies at the MGH between 1998 and 2007 – 105 of whom had a history of recovering from acute kidney injury and 24,640 with no history of kidney disease. Despite having normal results on the standard test for kidney function – the glomerular filtration rate – women with a history of acute kidney injury were more likely to develop preeclampsia (23 percent versus 4 percent) and to have cesarean deliveries (40 percent versus 27 percent). In addition to greater likelihood of being born early, their babies were more likely to be small for their gestational age and to require intensive care treatment.
After adjustment for several factors, a history of acute kidney injury was associated with a 2.4 times greater risk of any adverse fetal outcome and a 5.9 times greater risk of preeclampsia. While the reason behind this increased risk is unclear, it’s possible that changes known to take place in small blood vessels within in the kidneys during recovery from acute kidney injury may compromise the organ’s ability to cope with the demands of pregnancy. “We know that kidneys undergo major changes during pregnancy, and that sort of ‘renal stress test’ may reveal previously undetected kidney disease in women with a history of acute kidney injury,” says Tangren.
Jeffrey Ecker, MD, chief of Obstetrics and Gynecology at MGH, says, “Information like this helps obstetric providers know what to be vigilant for in pregnant women with a history of acute kidney injury and indicates that asking about such history is important. Being especially watchful for signs and symptoms of preeclampisa in such patients is one immediate application of this work. In a longer view, work like this offers important hypotheses for future study. Can interventions in patients with a history of acute kidney injury prevent complications like preeclampsia? Taking a baby aspirin each day during pregnancy is recommended for some women at high risk for preeclampsia. Should such preventative treatment be used in women with a history of acute kidney injury? Questions like this deserve further thought and study.” A co-author of the current study, Ecker is the Meigs Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School (HMS).
Ravi Thadhani, MD, MPH, chief of the MGH Division of Nephrology and a professor of Medicine at HMS, is senior author of the Journal of the American Society of Nephrology report. Additional co-authors are Camille Powe, MD, MGH Division of Endocrinology; Elizabeth Ankers, MGH Division of Nephrology; Kate Bramham, MD, PhD, King’s College London; Michelle Hladunewich, MD, MS, University of Toronto; and Ananth Karumanchi, MBBS, Beth Israel Deaconess Medical Center, Boston. The study was supported by National Institutes of Health grants T32 DK007540-30, T32 DK007028-41 and K24 DK094872-05.
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $800 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2016 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America’s Best Hospitals."
Press ReleaseDec | 22 | 2016